PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+12.51%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.86B
AUM Growth
+$246M
(+15%)
Cap. Flow
+$92.3M
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91
Top Buys
| 1 |
Apple
AAPL
|
+$14.3M |
| 2 |
Microsoft
MSFT
|
+$13.6M |
| 3 |
NVIDIA
NVDA
|
+$9.72M |
| 4 |
Tesla
TSLA
|
+$6.46M |
| 5 |
Amazon
AMZN
|
+$5.87M |
Top Sells
| 1 |
IMGN
Immunogen Inc
IMGN
|
+$3.55M |
| 2 |
Fiserv
FI
|
+$3.33M |
| 3 |
Exxon Mobil
XOM
|
+$2.48M |
| 4 |
Chevron
CVX
|
+$2.02M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$1.23M |
Sector Composition
| 1 | Technology | 37.9% |
| 2 | Healthcare | 15.37% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Communication Services | 8.94% |
| 5 | Energy | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Agios Pharmaceuticals
AGIO
$2.12B
| $854K | 0.05% |
30,144
-8,380
| -22% | -$237K |
|
352
Editas Medicine
EDIT
$251M
| $852K | 0.05% |
103,503
-22,239
| -18% | -$183K |
|
353
Colgate-Palmolive
CL
$68B
| $851K | 0.05% |
11,045
-48
| -0.4% | -$3.7K |
|
354
Aon
AON
$79.8B
| $846K | 0.05% |
2,450
-53
| -2% | -$18.3K |
|
355
Rocket Pharmaceuticals
RCKT
$352M
| $845K | 0.05% |
42,502
-13,014
| -23% | -$259K |
|
356
Royal Gold
RGLD
$12.3B
| $843K | 0.05% |
7,347
-208
| -3% | -$23.9K |
|
357
Zillow
Z
$21.8B
| $843K | 0.05% |
16,776
+662
| +4% | +$33.3K |
|
358
Vulcan Materials
VMC
$39.5B
| $840K | 0.05% |
3,724
+183
| +5% | +$41.3K |
|
359
Jazz Pharmaceuticals
JAZZ
$7.88B
| $838K | 0.04% |
6,757
+282
| +4% | +$35K |
|
360
Opendoor
OPEN
$4.45B
| $836K | 0.04% |
207,997
-14,568
| -7% | -$58.6K |
|
361
Arcellx
ACLX
$3.94B
| $833K | 0.04% |
26,345
+56
| +0.2% | +$1.77K |
|
362
Biohaven
BHVN
$1.53B
| $833K | 0.04% |
34,819
-31,189
| -47% | -$746K |
|
363
Box
BOX
$4.8B
| $829K | 0.04% |
28,220
+2,353
| +9% | +$69.1K |
|
364
Banco Bradesco
BBD
$33.3B
| $827K | 0.04% |
239,149
+3,027
| +1% | +$10.5K |
|
365
Viatris
VTRS
$12.2B
| $827K | 0.04% |
82,868
+6,806
| +9% | +$67.9K |
|
366
TE Connectivity
TEL
$61.4B
| $824K | 0.04% |
5,880
+1,541
| +36% | +$216K |
|
367
Illinois Tool Works
ITW
$77.7B
| $823K | 0.04% |
3,289
+252
| +8% | +$63K |
|
368
Arcturus Therapeutics
ARCT
$484M
| $820K | 0.04% |
28,608
-887
| -3% | -$25.4K |
|
369
Helmerich & Payne
HP
$1.99B
| $820K | 0.04% |
23,132
+1,242
| +6% | +$44K |
|
|
VERV
370
DELISTED
Verve Therapeutics
VERV
| $818K | 0.04% |
43,602
-5,125
| -11% | -$96.1K |
|
371
Fate Therapeutics
FATE
$111M
| $815K | 0.04% |
171,261
-83,728
| -33% | -$399K |
|
|
ICPT
372
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $815K | 0.04% |
73,688
+25,860
| +54% | +$286K |
|
373
PPL Corp
PPL
$26.4B
| $812K | 0.04% |
30,681
-2,768
| -8% | -$73.2K |
|
374
Valaris
VAL
$3.65B
| $811K | 0.04% |
12,888
+302
| +2% | +$19K |
|
375
NOV
NOV
$4.92B
| $810K | 0.04% |
50,476
+7,117
| +16% | +$114K |
|